v3.26.1
Business and Summary of Significant Accounting Policies (Details Narrative)
2 Months Ended 12 Months Ended
Feb. 28, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
Integer
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Subsequent Event [Line Items]        
Net loss   $ 15,305,000 $ 1,934,000  
Cash flow from operations   4,008,000 1,167,000  
Stockholders' deficit   5,879,000 5,698,000 $ 5,244,000
Notes payable   1,116,000    
Cash on Hand   6,000 150,000  
Proceeds warrants exercise   1,603,000 52,000  
Asset impairment   0 0  
Research and development costs   $ 1,611,000 $ 191,000  
Operating segment | Integer   1    
Reportable segment | Integer   1    
Stock Options [Member]        
Subsequent Event [Line Items]        
Antidilutive shares | shares   69,015,001 25,294,103  
Warrants [Member]        
Subsequent Event [Line Items]        
Antidilutive shares | shares   45,622,728 44,044,009  
Convertible Notes [Member]        
Subsequent Event [Line Items]        
Antidilutive shares | shares   16,408,334 48,304,534  
Patent Costs [Member]        
Subsequent Event [Line Items]        
Operating expenses   $ 5,000 $ 34,000  
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Shares issued | shares 4,718,188      
Proceeds warrants exercise $ 472,000